Holen Sie sich die Stockscreener-App
10.56
2.04%
-0.22
Handel nachbörslich:
10.77
0.21
+1.99%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.78
Offen:
$10.75
24-Stunden-Volumen:
1.19M
Relative Volume:
1.18
Marktkapitalisierung:
$902.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.16M
KGV:
-19.20
EPS:
-0.55
Netto-Cashflow:
$-29.31M
1W Leistung:
-3.74%
1M Leistung:
-4.95%
6M Leistung:
+24.68%
1J Leistung:
+64.49%
1-Tages-Spanne:
$10.25
$10.98
1-Wochen-Bereich:
$10.25
$11.70
52-Wochen-Spanne:
$4.9301
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corporation
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Vergleichen Sie AVXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
10.56 | 920.79M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript - Insider Monkey
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire
Can a trend reversal in Anavex Life Sciences Corp. lead to recoveryChart Signals & High Accuracy Swing Trade Signals - Newser
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - Connecticut Post
Achieve Life Sciences, Inc. shares rise 2.42% after-hours following positive earnings report. - AInvest
Earnings call transcript: Anavex Life Sciences Q3 2025 sees R&D drop - Investing.com UK
Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update - The Globe and Mail
Anavex Life Sciences Corp. Q3 Loss Increases, Misses Estimates - Nasdaq
Anavex Life Sciences Fiscal Q3 Loss Widens - MarketScreener
Anavex Life Sciences Corp. Reports Q3 Fiscal 2025 Financial Results and Webcast Announcement - Quiver Quantitative
Anavex Reports Breakthrough: Oral Alzheimer's Drug Maintains Benefits After 4 Years as Cash Position Tops $100M - Stock Titan
Anavex Life Sciences Amends Executive Employment Contracts - MSN
How high can Anavex Life Sciences Corp. stock goRSI and MACD Signal Summary with Trends - Newser
Understanding Anavex Life Sciences Corp.’s price movementSmart Trade Mapping with Entry Details - Newser
Why Anavex Life Sciences Corp. stock attracts strong analyst attentionSwing Watchlist With Tight Stop Placement - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Stock Entry Points Based on Technicals - Newser
Historical volatility pattern of Anavex Life Sciences Corp. visualizedEquity Portfolio Outlook and Performance Summary - Newser
Real time social sentiment graph for Anavex Life Sciences Corp.Market Sentiment Tracker with Smart Alerts - Newser
What technical models suggest about Anavex Life Sciences Corp.’s comebackPrice Movement and Market Sentiment Analysis - Newser
Published on: 2025-08-10 02:07:10 - Newser
Can Anavex Life Sciences Corp. recover in the next quarterROI Focused Setup Screener With Exit Markers - Newser
How Resilient Is Anavex Life Sciences Corp. Stock During Economic DownturnsFree Risk Controlled Short Term Trade Plans - Newser
Is Anavex Life Sciences Corp. stock reversal real or fakeIntraday Price Forecast Using Volume Models - Newser
Will Anavex Life Sciences Corp. outperform the marketVolume Spike Detection for Early Breakouts - Newser
Risk adjusted return profile for Anavex Life Sciences Corp. analyzedChart Signal and Short-Term Forecast Tracker - Newser
Envestnet Asset Management Inc. Sells 6,064 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Identifying reversal signals in Anavex Life Sciences Corp.Trend Following Ideas with Volume Confirmation - Newser
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Finan - GuruFocus
Anavex Life Sciences Corp. Schedules Third Quarter Financial Results and Conference Call for August 12, 2025 - Quiver Quantitative
Anavex Life Sciences Earnings: Latest Updates on Alzheimer's and Parkinson's Drug Development Coming August 12 - Stock Titan
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 - The Manila Times
Alzheimer's Disease Disease-Modifying Therapies Markets, 2023-2025 & 2026-2030 | Key Marketed Products, Clinical Trials, Competitive Scenario and R&D Activities - GlobeNewswire Inc.
What data driven models say about Anavex Life Sciences Corp.’s futureFree Stock Market Watch With Alerts - Newser
Can Anavex Life Sciences Corp. rally from current levelsHigh Confidence Strategy with Trend Alignment - Newser
Is Anavex Life Sciences Corp. stock a growth or value playDay Trading Setup Forecast with Trend Model - Newser
What catalysts could drive Anavex Life Sciences Corp. stock higher in 2025Maximize your gains with expert trading tips - Jammu Links News
What institutional investors are buying Anavex Life Sciences Corp. stockGet real-time alerts on top-performing stocks - Jammu Links News
Should I hold or sell Anavex Life Sciences Corp. stock in 2025Get timely alerts on market movers - Jammu Links News
Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):